Feb. 07, 2022

HARRISBURG – Aiming to ensure Pennsylvanians have access to additional COVID-19 treatments, the House Health Committee advanced today legislation by Rep. Dawn Keefer (R-York/Cumberland) to allow for prescribing and dispensing drugs approved by the United States Food and Drug Administration (FDA) for off-label use to treat coronavirus infections.

“These drugs have already been approved by the FDA and, in some cases, are already being successfully used to treat COVID-19,” Keefer said. “Additional patients deserve the same opportunities others have already experienced.”

House Bill 1741 would allow prescribers to prescribe and allow a pharmacist to dispense a therapeutic drug approved by the FDA without the threat of punitive action from the state, so long as it is in accordance with a prescription drug order and with the patient’s consent.

In addition, Keefer’s bill would allow for healthcare professionals to utilize FDA-approved, repurposed drugs for preventative and early-stage outpatient treatment, as well as hospital inpatient treatment, to meet needs of a patient infected with COVID-19. Physicians and pharmacists are being threatened and investigated by the state for merely treating covid-19, this bill puts a stop to such punitive action.

House Bill 1741 now goes to the full House for consideration.

To watch Rep. Dawn Keefer’s on the bill, click here.

To download the clip for distribution, click on the three dots in the lower right corner and then click “download."

Representative Dawn Keefer
92nd Legislative District
Pennsylvania House of Representatives

Media Contact: Greg Gross
RepKeefer.com / Facebook.com/RepKeefer